Technical description
Niraparib tosylate is an antineoplastic agent belonging to the class of poly(ADP-ribose) polymerase (PARP) inhibitors. It is a potent, selective oral drug targeting PARP-1 and PARP-2, used primarily as maintenance therapy for various types of advanced or recurrent ovarian cancer, including those of the fallopian tubes or primary peritoneal cancer.